Literature DB >> 9110389

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

E Dimenäs1, G Carlsson, H Glise, B Israelsson, I Wiklund.   

Abstract

This article presents the relevance of norm values to a battery of Quality of Life questionnaires for use in upper gastrointestinal disorders. The derivation of reference values offers an important contribution by confirming the ability of the questionnaires to differentiate patients from healthy controls. Two self-administered questionnaires, the Psychological General Well-being (PGWB) index and the Gastrointestinal Symptom Rating Scale (GSRS) were used. The norm values were derived in a randomly selected sample from a Swedish population consisting of 4624 individuals (reference group). The patients comprised more than 900 patients with gastroesophageal reflux disease (GORD) included in clinical trials. In the reference group, males reported significantly higher values on well-being as compared with women, whereas women reported more pronounced gastrointestinal symptoms than men. Generally, the younger persons and the group aged 60-70 years reported the highest well-being. Among gastrointestinal patients women scored lower and reported more symptoms than men. With increasing age, well-being improved and symptoms declined. Even though the well-being and symptoms scores differed between patient and the reference group similar patterns in terms of age and gender were observed. In summary, the results show that there are differences with respect to gender and age among normal controls as well as in GORD patients. These aspects have to be considered in clinical studies. The results also support the discriminative ability of the Quality of Life instruments.

Entities:  

Mesh:

Year:  1996        PMID: 9110389     DOI: 10.3109/00365529609095544

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  83 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Development of a frequent heartburn index.

Authors:  Donald E Stull; Patricia van Hanswijck de Jonge; Katherine Houghton; Christopher Kocun; David W Sandor
Journal:  Qual Life Res       Date:  2011-01-12       Impact factor: 4.147

3.  Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet.

Authors:  Henna Pekki; Kalle Kurppa; Markku Mäki; Heini Huhtala; Harri Sievänen; Kaija Laurila; Pekka Collin; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

4.  One- and ten-year outcome of laparoscopic anterior 120° versus total fundoplication: a double-blind, randomized multicenter study.

Authors:  Pauline Djerf; Agneta Montgomery; Bengt Hallerbäck; Hans-Olof Håkansson; Folke Johnsson
Journal:  Surg Endosc       Date:  2015-04-01       Impact factor: 4.584

5.  Bone Mineral Density in Boys Diagnosed with Autism Spectrum Disorder: A Case-Control Study.

Authors:  Kelly Barnhill; Lucas Ramirez; Alan Gutierrez; Wendy Richardson; C Nathan Marti; Amy Potts; Rebeca Shearer; Claire Schutte; Laura Hewitson
Journal:  J Autism Dev Disord       Date:  2017-11

6.  Rikkunshito, a traditional Japanese medicine, may relieve abdominal symptoms in rats with experimental esophagitis by improving the barrier function of epithelial cells in esophageal mucosa.

Authors:  Hiroto Miwa; Junichi Koseki; Tadayuki Oshima; Takashi Kondo; Toshihiko Tomita; Jiro Watari; Takayuki Matsumoto; Tomohisa Hattori; Kunitsugu Kubota; Seiichi Iizuka
Journal:  J Gastroenterol       Date:  2009-12-18       Impact factor: 7.527

7.  Posterior laryngitis: a study of persisting symptoms and health-related quality of life.

Authors:  Hillevi Pendleton; Marianne Ahlner-Elmqvist; Magnus Jannert; Bodil Ohlsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-29       Impact factor: 2.503

8.  Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

Authors:  Hiroaki Kusunoki; Masayasu Kusaka; Soichiro Kido; Ryo Yamauchi; Yoshinori Fujimura; Yasuyuki Watanabe; Michio Kobori; Hiroto Miwa; Toshihiko Tomita; Yongmin Kin; Kazutoshi Hori; Nobuo Tano; Kenji Sugimoto; Yoshihiro Nakamura; Kazuma Fujimoto; Noriko Oza; Aki Matsunobu; Naofumi Ono; Seisuke Fuyuno; Yoshikazu Kinoshita; Kyoichi Adachi; Mika Yuki; Tomoo Fujisawa; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-03-13       Impact factor: 7.527

Review 9.  Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  D Korolija; S Sauerland; S Wood-Dauphinée; C C Abbou; E Eypasch; M García Caballero; M A Lumsden; B Millat; J R T Monson; G Nilsson; R Pointner; W Schwenk; A Shamiyeh; A Szold; E Targarona; B Ure; E Neugebauer
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.